Julia C. Martins

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Does timing matter? Rethinking immunotherapy strategies in locally advanced cervical cancer.

Does timing matter? Rethinking immunotherapy strategies in locally advanced cervical cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 28, 2026

European Society for Medical Oncology Gynaecological Cancers Congress 2026: key scientific advances from the oral sessions.

European Society for Medical Oncology Gynaecological Cancers Congress 2026: key scientific advances from the oral sessions.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 19, 2026

Lymphovascular space invasion in cervical cancer: beyond the binary.

Lymphovascular space invasion in cervical cancer: beyond the binary.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 01, 2026

How long is enough? Immunotherapy duration in mismatch repair deficient endometrial cancer.

How long is enough? Immunotherapy duration in mismatch repair deficient endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 27, 2026

Beyond MEK inhibition: exploring MAPK pathway dependency in low-grade serous ovarian carcinoma.

Beyond MEK inhibition: exploring MAPK pathway dependency in low-grade serous ovarian carcinoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 23, 2026

Small findings, big questions: do isolated tumor cells matter in low-risk endometrial cancer?

Small findings, big questions: do isolated tumor cells matter in low-risk endometrial cancer?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 28, 2026

Between biology and benefit: who gains from PARP-immunotherapy in p53-abnormal endometrial cancer?

Between biology and benefit: who gains from PARP-immunotherapy in p53-abnormal endometrial cancer?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 28, 2026

Balancing biology and burden: rethinking chemotherapy in low-grade serous ovarian carcinoma.

Balancing biology and burden: rethinking chemotherapy in low-grade serous ovarian carcinoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 23, 2026

From metformin to glucagon-like peptide-1 receptor agonists: can metabolic modulation enhance progestin therapy for endometrial cancer?

From metformin to glucagon-like peptide-1 receptor agonists: can metabolic modulation enhance progestin therapy for endometrial cancer?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 05, 2026

Response to pembrolizumab in a patient with xeroderma pigmentosum, metastatic cutaneous melanoma and multiple squamous cell carcinomas: a case report.

Response to pembrolizumab in a patient with xeroderma pigmentosum, metastatic cutaneous melanoma and multiple squamous cell carcinomas: a case report.

Journal: Skin health and disease
Published: October 02, 2025

When the blood speaks first: circulating tumor DNA as a biomarker in locally advanced cervical cancer.

When the blood speaks first: circulating tumor DNA as a biomarker in locally advanced cervical cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 16, 2025

Clinical aspects and therapeutic approach of drug-induced adverse skin reactions in a quaternary hospital: a retrospective study with 219 cases.

Clinical aspects and therapeutic approach of drug-induced adverse skin reactions in a quaternary hospital: a retrospective study with 219 cases.

Journal: Anais brasileiros de dermatologia
Published: May 17, 2021
Showing 1-12 of 13

Last Updated: 09/26/2026